arrow
N

Naomi Hayashi

department of clinical genetic oncology
H指数:17
被引数:1,018

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline pathogenic variants in Japanese adolescents and young adults with advanced solid tumors: a nationwide tumor–normal paired sequencing study

日本青少年及年轻晚期实体瘤患者中的胚系致病变异:一项全国性肿瘤-正常配对测序研究

2026-07-270
PRE
NTRK-rearranged soft tissue sarcoma that originated from the head and neck with a robust response to the TRK inhibitor larotrectinib

NTRK重排的头颈部软组织肉瘤,其对TRK抑制剂larotrectinib表现出显著反应

2025-12-010
PRE
The Geriatric Nutritional Risk Index as a prognostic factor in older adult patients with locally advanced head and neck cancer receiving definitive chemoradiotherapy with tri-weekly cisplatin

老年营养风险指数作为接受三周顺铂确定性放化疗的局部晚期头颈癌老年患者的预后因素

2023-06-015
PRE
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients

在放射性碘难治性甲状腺癌患者中启动来伐替尼治疗的拟议临床评分系统

2022-01-287
PRE
Randomised phase II trial of capecitabine plus oxaliplatin with continuous versus intermittent use of oxaliplatin as adjuvant chemotherapy for stage II/III colon cancer (CCOG-1302 study)
2021-02-015
PREAI
The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)

CapeOX联合贝伐单抗治疗继之以卡培他滨联合贝伐单抗维持治疗转移性结直肠癌患者的疗效和安全性: 一项多中心、单臂、II期研究 (CCOG-0902)

2017-04-0413
OAAI